Alejandro Rodriguez-Garcia

Prof. Dr. Alejandro Rodriguez-Garcia

Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Nuevo León, Mexico
orcid
Academic Director of the Ophthalmology Residency Program

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1996 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
ARAlejandro Rodriguez
Alejandro Rodriguez
MCMargarita Calonge
Margarita Calonge
MPMiguel Pedroza-Seres
Miguel Pedroza-Seres
YAYonca A. Akova
Yonca A. Akova
EMElisabeth M. Messmer
Elisabeth M. Messmer
CFC. Stephen Foster
C. Stephen Foster
Objective: To analyze the referral patterns and diagnosis of uveitis during the past decade in a large tertiary eye center. Design: The records of 1237 patients with uveitis referred to the Immunology Service of the Massachusetts Eye and Ear Infirmary from 1982 to 1992 were classified and analyzed. Data regarding sex, race, nationality, referral site, ages at presentation and onset of uveitis, ocular involvement, clinical characteristics, ocular condition, and systemic disease associations were obtained. Results: The mean age at onset of uveitis was 37.2 years; the male-to-female ratio was 1:1.4. Most patients were white (85.8%), born in the United States (83.1%), and referred from within New England (84.7%). Anterior uveitis was most common (51.6%), followed by posterior uveitis (19.4%), panuveitis (16.0%), and intermediate uveitis (13.0%). Chronic (58.3%), nongranulomatous (77.7%), and noninfectious (83.1%) were the most frequent types of uveitis. The most common entities included idiopathic (34.9%), seronegative spondyloarthropathies (10.4%), sarcoidosis (9.6%), juvenile rheumatoid arthritis (5.6%), systemic lupus erythematosus (4.8%), Behçet's disease (2.5%), and the acquired immunodeficiency syndrome (2.4%). Conclusion: The appearance of new uveitic entities, such as the acute retinal necrosis syndrome, multifocal choroiditis and panuveitis, birdshot retinochoroidopathy, and acquired immunodeficiency syndrome—related uveitis, and the reemergence of the classic infectious causes of uveitis, tuberculosis and syphilis, have changed the way we approach the diagnosis and management of posterior and panuveitis at the Massachusetts Eye and Ear Infirmary.

24 September 1999 in Ophthalmologica
Verified
Journal Article
Closed access
PDF file
JMJesús Merayo-Lloves
Jesús Merayo-Lloves
WPWilliam J. Power
William J. Power
ARAlejandro Rodriguez
Alejandro Rodriguez
MPMiguel Pedroza-Seres
Miguel Pedroza-Seres
CFC. Stephen Foster
C. Stephen Foster
Purpose: To evaluate the prevalence of secondary glaucoma (SG), clinical forms of uveitis more frequently associated with glaucoma, and describe the treatment and complications encountered in a cohort of patients with glaucoma and uveitis during a 10-year period. Methods: The hospital records of patients with uveitis referred to the Immunology Service of the Massachusetts Eye and Ear Infirmary for a decade were reviewed for cases of SG. Results: One hundred and twenty of the 1,254 patients (9.6%) with uveitis developed SG. SG was more frequent in anterior uveitis (67%) but was also associated with posterior uveitis (13%) and pars planitis (4%). Herpetic keratouveitis (22%), Fuchs’ iridocyclitis (19%), juvenile rheumatoid arthritis-associated iridocyclitis (16%), syphilis (14%), and sarcoidosis (12%) were the leading types of uveitis associated with SG. Despite aggressive medical and surgical therapy, SG was associated with progressive visual field loss and optic nerve damage in 39 patients (33%). Conclusion: SG is an underappreciated, vision-threatening complication in patients with uveitis. Increased vigilance for emergence of this complicating problem during the care of patients with uveitis is warranted, and medical and surgical treatment for reducing IOP should be especially aggressive in these patients. We hypothesize that earlier, more aggressive treatment of uveitis will reduce the presence of glaucoma as an additional vision-robbing complication of uveitis.

1 July 1994 in Ophthalmology
Verified
Journal Article
Closed access
ARAlejandro Rodriguez
Alejandro Rodriguez
YAYonca A. Akova
Yonca A. Akova
MPMiguel Pedroza-Seres
Miguel Pedroza-Seres
CFC. Stephen Foster
C. Stephen Foster

1 August 1995 in Nature
Verified
Journal Article
Open access
PDF file
AAAnne C. Avery
Anne C. Avery
ZZZi-Shan Zhao
Zi-Shan Zhao
ARAlejandro Rodriguez
Alejandro Rodriguez
EBElizabeth K. Bikoff
Elizabeth K. Bikoff
MSMasoud Soheilian
Masoud Soheilian
HCHarvey Cantor
Harvey Cantor
NOT all peripheral tissue antigens enter the thymus and it is unclear how the immune system remains tolerant to this class of self antigen. As tolerance to self peptides can generate gaps in the T-cell repertoire for cross-reactive foreign antigens1,2, we investigated whether this mechanism might also diminish autoimmune reactions to similar peptides expressed by peripheral tissues. Herpes stromal keratitis (HSK) is a virally induced autoimmune reaction against corneal tissues mediated by T cells3á¤-5, and is a leading cause of human blindness6. Resistance to HSK in mice is associated with allotypic variation in immunoglobulin genes7,8, possibly because circulating immunoglobin-derived peptides can cross-tolerize T cells specific for corneal tissue autoantigens. Here we show that HSK is mediated by T-cell clones specific for corneal self antigens which also recognize an allotype-bearing peptide derived from IgG2a, and that exposure of HSK-susceptible mice to a soluble form of this peptide confers resistance to HSK. Shared expression of peptide subsequences between sequestered tissue proteins and circulating proteins may be important for maintenance of self-tolerance and prevention of autoimmunity.

1 May 1994 in Ophthalmology
Verified
Journal Article
Closed access
AVAlbert T. Vitale
Albert T. Vitale
ARAlejandro Rodriguez
Alejandro Rodriguez
CFC. Stephen Foster
C. Stephen Foster

2 August 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JYJ J Yunis
J J Yunis
NMN Mobini
N Mobini
EYE J Yunis
E J Yunis
CAC A Alper
C A Alper
RDR Deulofeut
R Deulofeut
AAA R Ahmed
A R Ahmed
Cicatricial pemphigoid (CP) is a chronic autoimmune blistering disease affecting multiple mucous membranes derived from stratified squamous epithelium and occasionally the skin. CP has a wide spectrum of disease manifestations. Patients with oral pemphigoid (OP) have a benign self-limited disease in which pathological changes are restricted to the oral mucosa. On the other hand, patients with ocular cicatricial pemphigoid (OCP), a chronic condition marked with relapses and remissions, have ocular involvement and also perhaps involvement of other mucous membranes. All clinical subsets are characterized by the presence of a similar anti-basement zone autoantibody. The factors that determine the development of one form of CP or the other are not known. In a previous study, we described the association between OCP and the DQB1*0301 allele (P = 0.006). In this study, we have analyzed 22 Caucasian patients with OP and their family members for major histocompatibility complex DRB generic, DQA1, and DQB1 allele associations by PCR-sequence-specific oligonucleotide probe hybridization. The results were compared to those obtained from 17 Caucasian patients with OCP and to control Caucasian alleles and haplotypes. The DQB1*0301 allele frequency was 38.6% in OP, 52.9% in OCP, and 17.8% in controls. Statistically significant associations were detected between the DQB1*0301 allele and both OP (P = 0.0047) and OCP (P < 0.0001). In addition, DRB1*04 showed a statistically significant association (P = 0.005) with OCP when compared to controls. Analysis of major histocompatibility complex class II haplotypes showed significant statistical associations between both OCP and OP and the HLA-DRB1*04, DRB4*0101, DQA1*03, DQB1*0301 haplotype (P < 0.0001 and P = 0.0012, respectively). Our results indicate that DQB1*0301 is a marker of both oral and ocular forms of CP. The analysis of the amino acid sequence of the DQB1 alleles present in both OP and OCP suggested that amino acid residues at position 57 and positions 71-77 may also be markers of CP.